Marinus Pharmaceuticals Inc Investor and Analyst Event Transcript
All right. Good morning, everybody. It's nice to see you all here in person. Welcome to the Marinus Pharmaceuticals 2023 Investor and Analyst Event. We're super excited about this because this is our first in-person event to do something like this, and so it's super exciting.
And I just want to extend additionally a really warm welcome to everybody that's joining us on the webcast. My name is Sonya Weigle and I'm the Senior Vice President of Investor Relations, Human Resources and Corporate Affairs at Marinus. I also want to introduce our newest colleague, the IR team, Jim DeNike, our Senior Director of Investor Relations.
Welcome, Jim. So today, I'm pleased to introduce today's speakers to share our agenda and to make some opening remarks. Before we begin, I'd just like to remind everyone -- but some of the statements made today are forward-looking statements under the securities laws. These forward-looking statements include substantial risks and uncertainties that could cause our clinical
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
